Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11680097 Antibodies against canine PD-1

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Date of Patent

June 20, 2023

0

Patent Application Number

168935290

Date Filed

June 5, 2020

0

Patent Citations

US Patent 7635757 B7-4 Antibodies and uses therefor

0

US Patent 7700301 Methods for screening for compounds that modulate PD-1 signaling

0

US Patent 7709214 Methods for upregulating an immune response with agents that inhibit the intereaction between PD-L2 and PD-1

0

US Patent 7722868 Agents that modulate the interaction of B7-1 polypeptide with PD-L1 and methods of use thereof

0

US Patent 7807158 Antibodies against IL-13 receptor alpha1 and uses thereof

0

US Patent 8008449 Human monoclonal antibodies to programmed death 1 (PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics

0

US Patent 8337842 Monoclonal antibodies

0

US Patent 8569460 Antibody constant domain regions and uses thereof

0

...

Patent Primary Examiner

Nelson B Moseley, II

0

The present invention discloses antibodies to canine PD-1 that have specific sequences and a high binding affinity for canine PD-1. The invention also discloses the use of the antibodies of the present invention in the treatment of cancer in dogs.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11680097 Antibodies against canine PD-1

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool